Ansell Limited announces that it has purchased a minority share of Yulex Corporation, a manufacturer of biopolymers derived from guayule. The investment is not expected to have any material impact on Ansell's earnings per share in fiscal years 2012 and 2013.
Further, Ansell and Yulex executed an exclusive agreement for the global development, manufacturing and distribution rights for medical gloves, personal protective equipment gloves, and condoms made of guayule latex.
Guayule (Parthenium argentatum) is a commercial crop (a small evergreen shrub) and the only rubber-producing species other than the Brazilian rubber tree (Hevea brasiliensis) that has been used for latex production on a commercial scale. Extensive scientific research suggests that guayule latex does not produce allergic reactions with natural rubber latex sensitive individuals. Â
Magnus Nicolin, CEO of Ansell Limited notes, "Our agreements with Yulex are an important step in our strategy to accelerate the development of new innovative products while reducing our usage of rubber tree latex."Â
"We are pleased to be partnering with Ansell," says Yulex Corporation CEO Jeff Martin. "Our collaboration will advance the acceptance of guayule natural rubber as a U.S. biobased alternative for natural rubber and petroleum-based rubber products.  We are committed to developing 'green' renewable technologies for consumer and healthcare markets."
Â
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.
Unmasking Long COVID: Dr Noah Greenspan on Recovery, Research Gaps, and the Future of Treatment
March 18th 2025Dr Noah Greenspan discusses the evolving understanding of long COVID, current treatment strategies, diagnostic challenges, and the critical need for research and awareness in post-viral syndromes.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.
Unmasking Long COVID: Dr Noah Greenspan on Recovery, Research Gaps, and the Future of Treatment
March 18th 2025Dr Noah Greenspan discusses the evolving understanding of long COVID, current treatment strategies, diagnostic challenges, and the critical need for research and awareness in post-viral syndromes.
2 Commerce Drive
Cranbury, NJ 08512